BMS-540215 ≥95%
Supplier: ADIPOGEN CORP MS
Synonyms:
(R)-1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-ol, Brivanib
SYN-1134-M001
SYN-1134-M005
SYN-1134-M010
SYN-1134-M050
102992-272EA
149.54
USD
102992-272
102992-274
102992-276
102992-278
BMS-540215 ≥95%
Brivanib (BMS-540215)
BMS-540215 is an ATP-competitive inhibitor of human VEGFR-2, with an IC(50) of 25nM and Ki of 26nM. BMS-540215 also showed good selectivity for FGFR-1 (IC(50) of 48nM), FGFR-2 (IC(50) of 125nM), and FGFR-3 (IC(50) of 68nM).
Formula:
C₁₉H₁₉FN₄O₃ MW: 370.4 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD13194684 CAS Number: 649735-46-6 |
Specification Test Results
Purity |
|
Appearance/Color | Solid. |
Solubility | Soluble in DMSO or ethanol. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...